Patents by Inventor David R. Hampton

David R. Hampton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10406066
    Abstract: Integrated devices for performing external chest compression (ECC) and defibrillation on a person and methods using the devices. Integrated devices can include a backboard, at least one chest compression member operably coupled to the backboard, and a defibrillator module operably coupled to the backboard. The integrated devices can include physiological sensors, electrodes, wheels, controllers, human interface devices, cooling modules, ventilators, cameras, and voice output devices. Methods can include defibrillating, pacing, ventilating, cooling, and performing ECC in an integrated, coordinated, and/or synchronous manner using the full capabilities of the device. Some devices include controllers executing methods for automatically performing the coordinated activities utilizing the device capabilities.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: September 10, 2019
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Cynthia Jayne, Ronald E. Stickney, Richard C. Nova, Stephen W. Radons, David R. Hampton, D. Craig Edwards, Joseph L. Sullivan, Steven E. Sjoquist
  • Patent number: 10213613
    Abstract: An external defibrillator system is disclosed that generates and applies a diagnostic signal to the patient in conjunction with defibrillation therapy. The diagnostic signal is designed to elicit a physiologic response from the patient's heart, namely, mechanical cardiac response and electrical cardiac response, electrical cardiac response only, or no cardiac response. Depending upon the type of cardiac response detected, the system selects an appropriate resuscitation protocol that considers the likely responsiveness of the patient to defibrillation therapy. In one practical embodiment, a stimulus signal is applied to patients that show mechanical and electrical capture in response to the diagnostic signal. The stimulus signal maintains the mechanical capture (and, therefore, perfusion) for a period of time prior to the delivery of a defibrillation pulse.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: February 26, 2019
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: David R. Hampton, Isabelle Banville
  • Patent number: 10046170
    Abstract: Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator whereby a user may override a CPR-first default protocol. The method includes following steps configured in a defibrillator controller of issuing an inquiry; waiting for a response to the inquiry for a set time; ordering a CPR treatment protocol if no response is received within the set time; analyzing a response; ordering a CPR treatment protocol upon receiving a non-affirmative response to the inquiry; and ordering a shock treatment protocol upon receiving an affirmative response to the inquiry. Upon selecting a shock treatment protocol, the defibrillator performs a shock analysis under the shock treatment protocol, and either orders a CPR treatment protocol if shock treatment is not indicated by the shock analysis or provides a defibrillation shock if shock treatment is indicated by the shock analysis. Queries may be presented to a user in visual, audible, or both visual and audible format.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: August 14, 2018
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Isabelle Banville, David R. Hampton, Gregory T. Kavounas, Richard C. Nova
  • Patent number: 9981142
    Abstract: Appropriate cardiac therapy is determined by data sensed and analyzed by the disclosed defibrillators and other medical devices that one or both of treat and monitor a patient. The disclosed devices sense various patient physiological parameters including patient pulse and breathing data to determine whether the patient has a pulse and to determine if the patient is breathing. Depending on the analysis of the generated patient physiological data, the disclosed devices determine the appropriate therapy for the patient, which can include providing breathing assistance to the patient and providing electrotherapy and other therapies to the patient. Some of the disclosed medical devices can be wearable by the patient. The disclosed devices can include therapy modules like electrotherapy for delivering therapies to the patient while other devices monitor but do not deliver the therapies to the patient.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: May 29, 2018
    Assignee: Physio-Control, Inc.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Patent number: 9950178
    Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: April 24, 2018
    Assignee: Physio-Control, Inc.
    Inventors: Ronald E. Stickney, James W. Taylor, Patricia O'Hearn, Cynthia P. Jayne, Paula Lank, David R. Hampton
  • Publication number: 20180028830
    Abstract: Appropriate cardiac therapy is determined by data sensed and analyzed by the disclosed defibrillators and other medical devices that one or both of treat and monitor a patient. The disclosed devices sense various patient physiological parameters including patient pulse and breathing data to determine whether the patient has a pulse and to determine if the patient is breathing. Depending on the analysis of the generated patient physiological data, the disclosed devices determine the appropriate therapy for the patient, which can include providing breathing assistance to the patient and providing electrotherapy and other therapies to the patient. Some of the disclosed medical devices can be wearable by the patient. The disclosed devices can include therapy modules like electrotherapy for delivering therapies to the patient while other devices monitor but do not deliver the therapies to the patient.
    Type: Application
    Filed: December 21, 2015
    Publication date: February 1, 2018
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Publication number: 20170266078
    Abstract: Resuscitation devices for performing external chest compression (ECC) and defibrillation on a person and methods using the devices are disclosed. The disclosed devices can include chest compression members and a communication module that can communicate with a remote command center. The disclosed devices can also include an optional defibrillation module that may be integrated. The devices can be coupled to a backboard and can include physiological sensors, electrodes, wheels, controllers, human interface devices, cooling modules, ventilators, cameras, and voice output devices. Methods can include defibrillating, pacing, ventilating, cooling, and performing ECC in an integrated, coordinated, and/or synchronous manner using the full capabilities of the device. Some devices include controllers executing methods for automatically performing the coordinated activities utilizing the device capabilities.
    Type: Application
    Filed: June 7, 2017
    Publication date: September 21, 2017
    Applicant: PHYSIO-CONTROL, INC.
    Inventors: Cynthia Jayne, Ronald E. Stickney, Richard C. Nova, Stephen W. Radons, David R. Hampton, D. Craig Edwards, Joseph L. Sullivan, Steven E. Sjoquist
  • Publication number: 20160287890
    Abstract: An external defibrillator system is disclosed that generates and applies a diagnostic signal to the patient in conjunction with defibrillation therapy. The diagnostic signal is designed to elicit a physiologic response from the patient's heart, namely, mechanical cardiac response and electrical cardiac response, electrical cardiac response only, or no cardiac response. Depending upon the type of cardiac response detected, the system selects an appropriate resuscitation protocol that considers the likely responsiveness of the patient to defibrillation therapy. In one practical embodiment, a stimulus signal is applied to patients that show mechanical and electrical capture in response to the diagnostic signal. The stimulus signal maintains the mechanical capture (and, therefore, perfusion) for a period of time prior to the delivery of a defibrillation pulse.
    Type: Application
    Filed: June 20, 2016
    Publication date: October 6, 2016
    Inventors: David R. Hampton, Isabelle Banville
  • Publication number: 20160175604
    Abstract: Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator whereby a user may override a CPR-first default protocol. The method includes following steps configured in a defibrillator controller of issuing an inquiry; waiting for a response to the inquiry for a set time; ordering a CPR treatment protocol if no response is received within the set time; analyzing a response; ordering a CPR treatment protocol upon receiving a non-affirmative response to the inquiry; and ordering a shock treatment protocol upon receiving an affirmative response to the inquiry. Upon selecting a shock treatment protocol, the defibrillator performs a shock analysis under the shock treatment protocol, and either orders a CPR treatment protocol if shock treatment is not indicated by the shock analysis or provides a defibrillation shock if shock treatment is indicated by the shock analysis. Queries may be presented to a user in visual, audible, or both visual and audible format.
    Type: Application
    Filed: January 29, 2016
    Publication date: June 23, 2016
    Applicant: Physio-Control, Inc.
    Inventors: Isabelle Banville, David R. Hampton, Gregory T. Kavounas, Richard C. Nova
  • Patent number: 9370665
    Abstract: An external defibrillator system is disclosed that generates and applies a diagnostic signal to the patient in conjunction with defibrillation therapy. The diagnostic signal is designed to elicit a physiologic response from the patient's heart, namely, mechanical cardiac response and electrical cardiac response, electrical cardiac response only, or no cardiac response. Depending upon the type of cardiac response detected, the system selects an appropriate resuscitation protocol that considers the likely responsiveness of the patient to defibrillation therapy. In one practical embodiment, a stimulus signal is applied to patients that show mechanical and electrical capture in response to the diagnostic signal. The stimulus signal maintains the mechanical capture (and, therefore, perfusion) for a period of time prior to the delivery of a defibrillation pulse.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: June 21, 2016
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: David R. Hampton, Isabelle Banville
  • Publication number: 20160106992
    Abstract: Appropriate cardiac therapy is determined by data sensed and analyzed by the disclosed defibrillators and other medical devices that one or both of treat and monitor a patient. The disclosed devices sense various patient physiological parameters including patient pulse and breathing data to determine whether the patient has a pulse and to determine if the patient is breathing. Depending on the analysis of the generated patient physiological data, the disclosed devices determine the appropriate therapy for the patient, which can include providing breathing assistance to the patient and providing electrotherapy and other therapies to the patient. Some of the disclosed medical devices can be wearable by the patient. The disclosed devices can include therapy modules like electrotherapy for delivering therapies to the patient while other devices monitor but do not deliver the therapies to the patient.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 21, 2016
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Patent number: 9248304
    Abstract: Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator whereby a user may override a CPR-first default protocol. The method includes following steps configured in a defibrillator controller of issuing an inquiry; waiting for a response to the inquiry for a set time; ordering a CPR treatment protocol if no response is received within the set time; analyzing a response; ordering a CPR treatment protocol upon receiving a non-affirmative response to the inquiry; and ordering a shock treatment protocol upon receiving an affirmative response to the inquiry. Upon selecting a shock treatment protocol, the defibrillator performs a shock analysis under the shock treatment protocol, and either orders a CPR treatment protocol if shock treatment is not indicated by the shock analysis or provides a defibrillation shock if shock treatment is indicated by the shock analysis. Queries may be presented to a user in visual, audible, or both visual and audible format.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: February 2, 2016
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Isabelle Banville, David R. Hampton, Gregory T. Kavounas, Richard C. Nova
  • Patent number: 9248306
    Abstract: A cardiac pulse in a patient is determined by evaluating physiological signals in the patient. A medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided. The medical devices, or any portion thereof, can be worn by the patient or may be attached to the patient.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: February 2, 2016
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Publication number: 20150073490
    Abstract: An external defibrillator system is disclosed that generates and applies a diagnostic signal to the patient in conjunction with defibrillation therapy. The diagnostic signal is designed to elicit a physiologic response from the patient's heart, namely, mechanical cardiac response and electrical cardiac response, electrical cardiac response only, or no cardiac response. Depending upon the type of cardiac response detected, the system selects an appropriate resuscitation protocol that considers the likely responsiveness of the patient to defibrillation therapy. In one practical embodiment, a stimulus signal is applied to patients that show mechanical and electrical capture in response to the diagnostic signal. The stimulus signal maintains the mechanical capture (and, therefore, perfusion) for a period of time prior to the delivery of a defibrillation pulse.
    Type: Application
    Filed: May 20, 2014
    Publication date: March 12, 2015
    Applicant: Physio-Control, Inc.
    Inventors: DAVID R. HAMPTON, ISABELLE BANVILLE
  • Patent number: 8744577
    Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: June 3, 2014
    Assignee: Physio-Control, Inc.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Patent number: 8731658
    Abstract: An external defibrillator system is disclosed that generates and applies a diagnostic signal to the patient in conjunction with defibrillation therapy. The diagnostic signal is designed to elicit a physiologic response from the patient's heart, namely, mechanical cardiac response and electrical cardiac response, electrical cardiac response only, or no cardiac response. Depending upon the type of cardiac response detected, the system selects an appropriate resuscitation protocol that considers the likely responsiveness of the patient to defibrillation therapy. In one practical embodiment, a stimulus signal is applied to patients that show mechanical and electrical capture in response to the diagnostic signal. The stimulus signal maintains the mechanical capture (and, therefore, perfusion) for a period of time prior to the delivery of a defibrillation pulse.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: May 20, 2014
    Assignee: Physio-Control, Inc
    Inventors: David R. Hampton, Isabelle Banville
  • Patent number: 8663121
    Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: March 4, 2014
    Assignee: Physio-Control, Inc.
    Inventors: Ronald E. Stickney, James W. Taylor, Patricia O'Hearn, Cynthia P. Jayne, Paula Lank, David R. Hampton
  • Publication number: 20130338724
    Abstract: A cardiac pulse in a patient is determined by evaluating physiological signals in the patient. A medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided. The medical devices, or any portion thereof, can be worn by the patient or may be attached to the patient.
    Type: Application
    Filed: August 19, 2013
    Publication date: December 19, 2013
    Applicant: Physio-Control, Inc.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Patent number: 8532766
    Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: September 10, 2013
    Assignee: Physio-Control, Inc.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich
  • Publication number: 20120302896
    Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
    Type: Application
    Filed: August 7, 2012
    Publication date: November 29, 2012
    Applicant: PHYSIO-CONTROL, INC.
    Inventors: Tae H. Joo, Ronald E. Stickney, Cynthia P. Jayne, Paula Lank, Patricia O'Hearn, David R. Hampton, James W. Taylor, William E. Crone, Daniel Yerkovich